DK0814828T3 - Fremgangsmåde til fremstilling af et terapeutisk middel til regenereringen af oligodendrocytter - Google Patents

Fremgangsmåde til fremstilling af et terapeutisk middel til regenereringen af oligodendrocytter

Info

Publication number
DK0814828T3
DK0814828T3 DK96907391T DK96907391T DK0814828T3 DK 0814828 T3 DK0814828 T3 DK 0814828T3 DK 96907391 T DK96907391 T DK 96907391T DK 96907391 T DK96907391 T DK 96907391T DK 0814828 T3 DK0814828 T3 DK 0814828T3
Authority
DK
Denmark
Prior art keywords
oligodendrocytes
regeneration
therapeutic agent
preparation
treatment
Prior art date
Application number
DK96907391T
Other languages
Danish (da)
English (en)
Inventor
Juergen Unger
Ilse Bartke
Kurt Naujoks
Yorn Schmidt
Original Assignee
Scil Technology Holding Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scil Technology Holding Gmbh filed Critical Scil Technology Holding Gmbh
Application granted granted Critical
Publication of DK0814828T3 publication Critical patent/DK0814828T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK96907391T 1995-03-10 1996-03-08 Fremgangsmåde til fremstilling af et terapeutisk middel til regenereringen af oligodendrocytter DK0814828T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95103458A EP0731108A1 (fr) 1995-03-10 1995-03-10 Procédé de fabrication d'un agent thérapeutique pour la régénération d'oligodendrocytes
PCT/EP1996/000992 WO1996028180A1 (fr) 1995-03-10 1996-03-08 Procede de fabrication d'un agent therapeutique pour la regeneration des oligodendrocytes

Publications (1)

Publication Number Publication Date
DK0814828T3 true DK0814828T3 (da) 2003-09-29

Family

ID=8219056

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96907391T DK0814828T3 (da) 1995-03-10 1996-03-08 Fremgangsmåde til fremstilling af et terapeutisk middel til regenereringen af oligodendrocytter

Country Status (12)

Country Link
US (1) US6268340B1 (fr)
EP (2) EP0731108A1 (fr)
JP (1) JPH10504320A (fr)
AT (1) ATE241381T1 (fr)
AU (1) AU5103696A (fr)
CA (1) CA2214999A1 (fr)
DE (1) DE69628417T2 (fr)
DK (1) DK0814828T3 (fr)
ES (1) ES2194978T3 (fr)
MX (1) MX9706739A (fr)
PT (1) PT814828E (fr)
WO (1) WO1996028180A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0227900B1 (fr) * 1985-12-02 1993-03-31 International Business Machines Corporation Appareil de traitement de données à instructions à trois adresses
WO1998046254A1 (fr) * 1997-04-11 1998-10-22 Roche Diagnostics Gmbh Facteur de croissance du tissu nerveux pour la prevention de la demyelinisation dans le systeme nerveux
WO1998056403A1 (fr) * 1997-06-13 1998-12-17 Roche Diagnostics Gmbh Amelioration de la regeneration des gaines de myeline
US6123956A (en) * 1997-07-10 2000-09-26 Keith Baker Methods for universally distributing therapeutic agents to the brain
US6313089B1 (en) 1997-08-20 2001-11-06 Duke University Complexes of apolipoprotein E and ciliary neurotrophic factor (CNTF) and methods of use
JP2001518449A (ja) * 1997-09-30 2001-10-16 デューク・ユニバーシティー アポリポタンパク質ｅ／成長因子複合体およびその使用法
US7282482B2 (en) * 1998-04-08 2007-10-16 The Regents Of The University Of California NGF for the prevention of demyelination in the nervous system
JP2002204691A (ja) * 2001-01-09 2002-07-23 Japan Science & Technology Corp 神経細胞再髄鞘化のための移植用細胞キット
GB0119435D0 (en) 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
US7285415B2 (en) 2002-07-11 2007-10-23 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
DE4125933A1 (de) 1991-08-05 1993-02-11 Max Planck Gesellschaft Verbesserung der regeneration von oligodendrocyten
US5885584A (en) * 1991-08-05 1999-03-23 Boehringer Mannheim Gmbh Regeneration of oligodendrocytes

Also Published As

Publication number Publication date
JPH10504320A (ja) 1998-04-28
WO1996028180A1 (fr) 1996-09-19
DE69628417D1 (de) 2003-07-03
MX9706739A (es) 1997-11-29
CA2214999A1 (fr) 1996-09-19
US6268340B1 (en) 2001-07-31
EP0814828A1 (fr) 1998-01-07
ATE241381T1 (de) 2003-06-15
ES2194978T3 (es) 2003-12-01
EP0731108A1 (fr) 1996-09-11
PT814828E (pt) 2003-10-31
AU5103696A (en) 1996-10-02
DE69628417T2 (de) 2004-03-18
EP0814828B1 (fr) 2003-05-28

Similar Documents

Publication Publication Date Title
HU9303748D0 (en) Composition of l-dopa-esters
HU883981D0 (en) Process for the production of medical preparations with antiviral or antibacterial effect
NZ500763A (en) Use of PEG 12000-IFN alpha in treating viral infection
EP0416454A3 (en) Method of and apparatus for administering medicament to a patient
PH23867A (en) Method of treating parkinson's disease using indolone derivatives
MY108496A (en) Hypoglycemic thiazolidine diones.
PL338982A1 (en) Drug for improving duration of muscle action or for treating muscular disorders or diseases
DK0814828T3 (da) Fremgangsmåde til fremstilling af et terapeutisk middel til regenereringen af oligodendrocytter
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
JO1589B1 (en) Ketones (quaternary hydroimidazo (4.1) benzo-diazepine-2) anti-viral
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
ATE135909T1 (de) Verfahren zur behandlung von akne
EP0393707A3 (fr) Composés bio-actifs associés à des liposomes et leur utilisation dans des préparations pharmaceutiques
JPS6468320A (en) Remedy for psychotic disease or like and therapeutical solution
DK0396903T3 (da) Anvendelse af IFN-gamma til fremstilling af et farmaceutisk præparat til behandling af ATL
EP0175440A3 (fr) Procédé de traitement de maux de tête dus à la migraine
JPS6442423A (en) Remedy containing propaphenone antipode
IL107818A (en) Pharmaceutical compositions for treating viral infections by conjunctive therapy with acylovir-like compounds and a 2'-(halo) methylene nucleoside analog
MD197G2 (ro) Preparat şi procedeu de tratare a hipogalactiei
UA10219A (uk) Спосіб лікування туберкульозу легень
UA26326C2 (uk) Спосіб лікуваhhя захворюваhь вірусhої та бактеріальhої етіології у людиhи і твариhи та композиція для його реалізації
UA19521A (uk) Спосіб лікуваhhя періhатальhих ушкоджеhь мозку дітей
UA7056A1 (uk) Спосіб лікування запальних захворювань легень